Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses

A modular antigen-transporting molecule (MAT) comprising one each of a translocation module (TrM), a targeting module (TaM) and an antigen module (AM), is new. Modular antigen-transporting molecule (MAT) comprising at least one each of translocation module (TrM), targeting module (TaM) and antigen m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: LAMPING NORBERT,RETO CRAMERI,FLUECKIGER SABINE,DAIGLE ISABELLE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A modular antigen-transporting molecule (MAT) comprising one each of a translocation module (TrM), a targeting module (TaM) and an antigen module (AM), is new. Modular antigen-transporting molecule (MAT) comprising at least one each of translocation module (TrM), targeting module (TaM) and antigen module (AM) is new. TrM is able to transport MAT from the extracellular space into a cell; TaM directs transport of MAT to organelles involved in processing of antigens (Ag) or loading of MHC (major histocompatibility complex) molecules, and AM determines the specificity of the immune response induced by MAT. Independent claims are also included for the following: (1) method for preparing MAT; (2) nucleic acid (I) that encodes MAT; (3) vector containing (I) and preferably at least one of promoter, antibiotic or antimycotic resistance gene; (4) primary cells or cell lines containing a vector of (3) or (I); (5) vesicles, especially exosomes, deoxosomes or liposomes that contain at least one MAT, (I) or the vector of (3); (6) immunoglobulins (Ig), or their fragments, that recognize MAT, prepared by immunization of a human or animal; (7) method for identifying substances that inhibit or stimulate presentation of Ag through the MHC; (8) method for identifying specific epitopes of Ag; (9) in vitro cultured cells, human or animal, that have been treated with MAT, (I), the vector of (3) or vesicle of (5) and show modulated Ag presentation; and (10) method for preparing antibodies (Ab), using MAT, (I), vesicles of (5), or cells of (4) or (9), by immunization.